MedPath

Individualized rTMS for Motor Recovery in Stroke Patients

Not Applicable
Recruiting
Conditions
Stroke
Transcranial Magnetic Stimulation
Interventions
Device: Repetitive transcranial magnetic stimulation
Registration Number
NCT05914038
Lead Sponsor
National Taiwan University Hospital
Brief Summary

This study aimed to aim to investigate the efficacy of individualized rTMS according to lateralization index on motor recovery and cortical excitability in subacute stroke patients.

Detailed Description

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation technology.

High and low frequencies of rTMS could modulate the excitability of the cerebral cortex. Theta burst stimulation (TBS) has achieved a similar effect to traditional rTMS mode.

However, the current rTMS studies for stroke patients utilized the same therapeutic protocol and there is no individualized rTMS protocol based on the value of lateralization index.

This study aimed to aim to investigate the efficacy of individualized rTMS according to lateralization index on motor recovery and cortical excitability in subacute stroke patients.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Unilateral ischemic or hemorrhagic stroke
  2. Stroke within 3 months
  3. Medical Research Council Scale for Muscle Strength in upper limb ≤ 3
  4. No previous stroke, seizure, dementia, Parkinson's disease or other degenerative neurological diseases.
  5. Patient could sit over 15 minutes
  6. Age over 20
Exclusion Criteria
  1. Previous stroke, traumatic brain injury, brain tumor
  2. With central nervous system disease (spinal cord injury, Parkinson's disease)
  3. Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker)
  4. Patients unable to cooperate the treatment
  5. Pregnancy
  6. Depression

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
individualized rTMSRepetitive transcranial magnetic stimulationPatients will receive individualized repetitive transcranial magnetic stimulation according to lateralization index measured by functional near-infrared spectroscopy
Traditional rTMSRepetitive transcranial magnetic stimulationControl group is given traditional rTMS
Primary Outcome Measures
NameTimeMethod
Fugl-Meyer Assessment12 weeks post intervention

Fugl-Meyer Assessment motor function set, score: 0-66, higher scores indicate a better outcome.

Secondary Outcome Measures
NameTimeMethod
Barthel Index1 week, 4 weeks, 12 weeks post intervention

Barthel Index, score 100-0. Higher scores indicate a better outcome.

MEP1 week, 4 weeks, 12 weeks post intervention

motor evoked potential

Fugl-Meyer Assessment1 week, 4 weeks post intervention

Fugl-Meyer Assessment motor function set, score: 0-66, higher scores indicate a better outcome.

National Institutes of Health Stroke Scale1 week, 4 weeks, 12 weeks post intervention

National Institutes of Health Stroke Scale, The maximum possible score is 42, with the minimum score being a 0. Higher scores indicate a worse outcome.

Modified Rankin Scale1 week, 4 weeks, 12 weeks post intervention

Modified Rankin Scale, score from 0 to 6. Higher scores indicate a worse outcome.

functional NIRS1 week, 4 weeks, 12 weeks post intervention

Functional Near Infrared Spectroscopy to detect the cortical excitability

Medical Research Council (MRC) Scale for Muscle Strength1 week, 4 weeks, 12 weeks post intervention

Medical Research Council (MRC) Scale for Muscle Strength, assessing muscle strength from Grade 5 (normal) to Grade 0 (no visible contraction).

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei county, Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath